# OpenAI researcher Miles Wang in talks to launch an AI drug discovery startup

> Miles Wang, an OpenAI researcher who worked on using AI to accelerate scientific discovery, is in talks to leave and launch his own drug discovery startup. The early plans are ambitious: reports point to a raise of around 200 million dollars at a 2 billion dollar valuation, with Lightspeed Venture Partners in discussions to lead, all before the company has publicly shipped anything. The most interesting wrinkle is the reported focus. Rather than inventing molecules from nothing, the startup may hunt for new uses for drugs that already exist or that failed in earlier trials, a strategy where AI's pattern-finding could pay off quickly and cheaply. Repurposing sidesteps much of the cost and risk of designing novel compounds. It also fits a broader pattern of senior AI researchers peeling off from the big labs to apply frontier techniques to specific scientific domains. If even a fraction of the money now chasing general models flows into targeted problems like this, drug discovery could become one of the first places AI's scientific promise is tested in earnest.

_Section: [Daily AI Updates](https://www.wortins.com/daily-ai) · Source: TechCrunch · Published Saturday, July 18, 2026_

## Wortins' read

Miles Wang, an OpenAI researcher who worked on using AI to accelerate scientific discovery, is in talks to leave and launch his own drug discovery startup. The early plans are ambitious: reports point to a raise of around 200 million dollars at a 2 billion dollar valuation, with Lightspeed Venture Partners in discussions to lead, all before the company has publicly shipped anything. The most interesting wrinkle is the reported focus. Rather than inventing molecules from nothing, the startup may hunt for new uses for drugs that already exist or that failed in earlier trials, a strategy where AI's pattern-finding could pay off quickly and cheaply. Repurposing sidesteps much of the cost and risk of designing novel compounds. It also fits a broader pattern of senior AI researchers peeling off from the big labs to apply frontier techniques to specific scientific domains. If even a fraction of the money now chasing general models flows into targeted problems like this, drug discovery could become one of the first places AI's scientific promise is tested in earnest.

## Source

[Read the full story at TechCrunch](https://techcrunch.com/2026/07/14/openai-researcher-miles-wang-in-talks-to-launch-ai-drug-discovery-startup-valued-at-2b/)

## Related coverage

- [Anthropic Prepares for October IPO as Fable 5 Dominance Solidifies](https://www.wortins.com/story/anthropic-prepares-for-october-ipo-as-fable-5-dominance-soli-98c09b96) — [GuruFocus](https://www.gurufocus.com/news/8960658/anthropic-prepares-for-potential-ipo-outpacing-openai)
- [Healthcare AI Diagnostics Adoption Accelerates Despite Safety Concerns](https://www.wortins.com/story/healthcare-ai-diagnostics-adoption-accelerates-despite-safet-5b905590) — [Radiology Business](https://radiologybusiness.com/topics/artificial-intelligence/navigating-ai-diagnostic-dilemma-healthcares-no-1-patient-safety-concern-2026)
- [Hundreds of Experts Warn AI Could Displace Millions Without Policy Action](https://www.wortins.com/story/hundreds-of-experts-warn-ai-could-displace-millions-without--d97449d7) — [Al Jazeera](https://www.aljazeera.com/economy/2026/7/13/hundreds-of-experts-warn-the-world-must-prepare-now-for-ais-impact)
- [Scarlett](https://www.wortins.com/story/scarlett-6996176e) — [Product Hunt](https://tryscarlett.ai/)
- [The Hyperscaler AI Arms Race: Who Wins When $700B Goes to Compute?](https://www.wortins.com/story/the-hyperscaler-ai-arms-race-who-wins-when-700b-goes-to-comp-6a2a2419) — [Geekfence](https://geekfence.com/the-hyperscaler-ai-arms-race-reshaping-global-cloud-infrastructure/)
- [Meta Announces Surplus GPU Capacity Sales via New Meta Compute Cloud Unit](https://www.wortins.com/story/meta-announces-surplus-gpu-capacity-sales-via-new-meta-compu-c565dc15) — [Intellectia](https://intellectia.ai/blog/ai-infrastructure-investment-july-2026)

---

_Curated and written by [Wortins](https://www.wortins.com) — The daily AI briefing. Every story links to its original source; the "Wortins read" on each is our own original analysis. [About Wortins & our editorial approach](https://www.wortins.com/about)._